Bifeprunox is a D2 and 5-HT1A receptor partial agonist for schizophrenia research
**Background** Schizophrenia is a complex, chronic mental disorder characterized by positive symptoms, such as hallucinations and delusions, as well as negative symptoms, including social withdrawal and cognitive impairment. The pathophysiology…